Dr Reddys Laboratories Share Price Today - Live Blog for August 28, 2025

Dr Reddys Laboratories Ltd's stock price surged by 0.16%, reaching the current market value of ₹1,262.55 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.06% drop, and it's now trading at ₹1,260.25 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd shares saw a -0.08% decrease, reaching a current market price of ₹1,259.75. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.5600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a remarkable 0.02% surge in its share price and is presently trading at ₹1,260.00. The increased investor interest is driving this surge.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.07% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,259.85 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock price surged by 0.18%, reaching the current market value of ₹1,258.45 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's share price rallied by 0.02%, reaching the current market price of ₹1,255.30. This surge is indicative of the stock's recent positive performance.

There were no changes in the share price of Dr Reddys Laboratories Ltd, which is currently at ₹1,255.00. During this period of price stability, investors may review the stock's financials and market positioning.

Dr Reddys Laboratories Ltd displayed price stability, with no changes, and is trading at ₹1,255.00. While the stock's performance remains constant, it's worth noting that its PE ratio is 18.5600, while the industry PE is 34.6564.

Dr Reddys Laboratories Ltd's share price remained unchanged, indicating a period of stability in the market. As of now, the stock is still trading at ₹1,255.00. This static phase might encourage investors to assess their long-term strategies.

Dr Reddys Laboratories Ltd displayed no price movement, holding steady at ₹1,255.00. Interestingly, the stock maintains a Price-to-Earnings (PE) ratio of 18.5600, while the industry PE ratio stands at 34.6564, which might influence investors' decisions.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,255.00. Investors should examine the factors driving this decline. The stock's PE ratio is 18.5600, whereas the industry PE ratio stands at 34.6564.

Dr Reddys Laboratories Ltd's share price has fallen by -0.02%, a situation worth noting. At present, the stock is trading at ₹1,255.50. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.5600, while the industry PE ratio is 34.6564.

After a significant 0.01% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,255.70 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Dr Reddys Laboratories Ltd experienced a -0.04% slump and is currently trading at ₹1,255.70. While the stock maintains a PE ratio of 18.5600, the industry PE is 34.6564, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.02% recently. As of now, this stock is actively trading at a current market price of ₹1,256.40 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd shares saw a -0.04% decrease, reaching a current market price of ₹1,256.10. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.5600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.10%, and as of now, it's trading at ₹1,255.50 per share. This upward trajectory is attracting keen interest from investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.08% boost, with the current market value at ₹1,254.70 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.01% decline, and it currently trades at ₹1,250.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd experienced a -0.01% dip in its share price and is currently trading at ₹1,250.00. The stock has a PE ratio of 18.5600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.02% increase. Presently, it is actively trading at ₹1,251.00.

The share price of Dr Reddys Laboratories Ltd plunged by -0.04%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,250.55, but investors are assessing whether this is a temporary dip or a long-term trend.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.07% in its share price, and it currently trades at ₹1,254.50 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,254.25. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.5600, while the industry PE is 34.6564.

Dr Reddys Laboratories Ltd's share price has fallen by -0.68%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,256.35, and market participants are assessing the implications. The stock has a PE ratio of 18.5600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.